These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34678524)

  • 21. Left Atrial Appendage Occlusion With New Watchman-FLX Device.
    Garg J; Shah K; Shah S; Turagam MK; Natale A; Lakkireddy D
    Am J Cardiol; 2021 Sep; 154():135-137. PubMed ID: 34330451
    [No Abstract]   [Full Text] [Related]  

  • 22. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
    Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY
    Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications.
    Pillarisetti J; Reddy YM; Gunda S; Swarup V; Lee R; Rasekh A; Horton R; Massumi A; Cheng J; Bartus K; Badhwar N; Han F; Atkins D; Bommana S; Earnest M; Nath J; Ferrell R; Bormann S; Dawn B; Di Biase L; Mansour M; Natale A; Lakkireddy D
    Heart Rhythm; 2015 Jul; 12(7):1501-7. PubMed ID: 25778430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study.
    Swaans MJ; Post MC; Rensing BJ; Boersma LV
    J Am Heart Assoc; 2012 Oct; 1(5):e002212. PubMed ID: 23316289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghostly Cystic Mass Attached to a Watchman Left Atrial Appendage Occlusion Device Following
    Jiménez Martínez C; Del Castillo-Medina R; Robles Velasco P; Batlle López E; Vegas Serrano A; Anguita Gámez M; Campelos Fernández P; Saiz-Pardo Sanz M; Ortega Medina L; Botas Rodríguez J
    Circ Cardiovasc Imaging; 2021 Dec; 14(12):1159-1162. PubMed ID: 34852640
    [No Abstract]   [Full Text] [Related]  

  • 29. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
    J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.
    Cruz-González I; Korsholm K; Trejo-Velasco B; Thambo JB; Mazzone P; Rioufol G; Grygier M; Möbius-Winkler S; Betts T; Meincke F; Sandri M; Schmidt B; Schmitz T; Nielsen-Kudsk JE
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2732-2741. PubMed ID: 33189641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Watchman FLX: the initial Polish experience with a new device for left atrial appendage occlusion.
    Grygier M; Markiewicz A; Araszkiewicz A; Babicz-Sadowska A; Płaksej R; Komosa A; Trojnarska O; Lesiak M
    Kardiol Pol; 2020 Mar; 78(3):240-242. PubMed ID: 32024807
    [No Abstract]   [Full Text] [Related]  

  • 33. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential applicability and utilization of left atrial appendage occlusion devices in patients with atrial fibrillation.
    Fountain R; Holmes DR; Hodgson PK; Chandrasekaran K; Van Tassel R; Sick P
    Am Heart J; 2006 Oct; 152(4):720-3. PubMed ID: 16996847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
    Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined MitraClip implantation and left atrial appendage occlusion using the Watchman device: A case series from a referral center.
    Francisco ARG; Infante de Oliveira E; Nobre Menezes M; Carrilho Ferreira P; Canas da Silva P; Nobre Â; Pinto FJ
    Rev Port Cardiol; 2017; 36(7-8):525-532. PubMed ID: 28673783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occlusion of left atrial appendage to treat atrial fibrillation.
    Calvert PA; Rana BS; Begley DA; Shapiro LM
    Lancet; 2009 Nov; 374(9703):1742-3; author reply 1743. PubMed ID: 19932351
    [No Abstract]   [Full Text] [Related]  

  • 38. Percutaneous left atrial appendage closure: current state of the art.
    Jazayeri MA; Vuddanda V; Parikh V; Lakkireddy DR
    Curr Opin Cardiol; 2017 Jan; 32(1):27-38. PubMed ID: 27898435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
    Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
    Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.